default author photo

Jennifer Specht

University of Washington

Seattle, WA 98195

United States

SCHOLARLY PAPERS

2

DOWNLOADS

72

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

A Composite 18f-Fdg Pet/Ct and Her2 Tissue-Based Biomarker to Predict Response to Neoadjuvant Pertuzumab and Trastuzumab in Her2-Positive Breast Cancer (Tbcrc026)

Number of pages: 33 Posted: 27 Nov 2024
Cork University Hospital, affiliation not provided to SSRN, University of Alberta, Mayo Clinic, Mayo Clinic, Johns Hopkins University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Baylor College of Medicine, University of Washington, Indiana University - School of Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Texas at Houston - MD Anderson Cancer Center, Johns Hopkins University, affiliation not provided to SSRN, affiliation not provided to SSRN, Cornell University - Weill Cornell Medicine, Mayo Clinic and affiliation not provided to SSRN
Downloads 42 (1,170,409)

Abstract:

Loading...

18F-FDG PET/CT, HER2-Biomarkers, breast cancer, Neoadjuvant

2.

Concurrent chemotherapy with adjuvant radiation for patients with high-risk locally advanced breast cancer: safety and outcomes

Number of pages: 22 Posted: 29 Oct 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Illinois Chicago, affiliation not provided to SSRN, University of Washington, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 30 (1,332,057)

Abstract:

Loading...

Chemoradiation, locoregional recurrence, Breast Cancer, Stage 2, Stage 3